SLE had a greater impact on mortality and other poor outcomes than all the other comorbidities considered in a cross-sectional study of patients with COVID-19 in Brazil.
Brad Rovin, MD, and Richard Furie, MD, discussed the merits of dual therapy with voclosporin or belimumab in lupus nephritis but said response rates leave a lot of room for improvement.